The Bionics Institute is excited to announce the appointment of Robert Klupacs as its new Chief Executive Officer. Robert was appointed after an international search for a new CEO to lead the renowned medical research institute, which was founded in 1986 by Professor Graeme Clark, who developed the world’s first bionic ear in Melbourne. Professor Clark led the Institute for 10 years before handing the reins to Professor Rob Shepherd. Under his leadership, the Bionics Institute became a key partner in the team developing the next generation Australian bionic eye and has ground-breaking projects underway to treat debilitating conditions including epilepsy and Parkinson’s disease.

Robert Klupacs is a registered patent attorney with over 30 years’ experience in medical research and technology. Most recently he was Executive Chairman of Bionic Vision Technologies, which just secured funding for the next stage of the bionic eye development. Bionics Institute Chairman, John Stanhope, said Robert is an innovative leader who brings a range of skills to increase the Institute’s focus on translating research into real-world solutions.

“We welcome the contribution Robert Klupacs will make as we aggressively increase our focus on turning our technologies and inventions into products that make an impact in the lives of patients, while also bringing investment and jobs to Victoria and Australia,” said Mr Stanhope. “We thank Rob Shepherd for his enormous contribution to bionics in Australia and around the world – we are delighted that he will be staying on with the Institute as Principal Scientist.”

Robert Klupacs said he is passionate about ensuring translation of technology into clinically validated products to improve the lives of patients, and ensuring that these activities lead to a larger and well-funded medical technologies industry in Australia.

“Australia, and in particular Victoria, is renowned for its medical research but translating that
research into real-world outcomes remains challenging. The Bionics Institute is focused on solving clinical problems with a unique mix of engineering, clinical and research expertise,” said Mr Klupacs. “We have a wonderful opportunity to lead the world in bionic technology that changes lives. I’m honoured and excited about the opportunity to grow and enhance the Institute.”